Current Value of Holding

$664M

Shares

1.39M

% of Portfolio

26.05%

Average Buy Price

$225

Avg closing price
Price range

11 John Paulson Madrigal Pharmaceuticals Trades

John Paulson acquired 1.39M Madrigal Pharmaceuticals shares worth $664M. That's 26.05% of their entire equity portfolio (2nd largest holding). The investor owns 5.91% of the outstanding Madrigal Pharmaceuticals stock. John Paulson started to build up the position in Madrigal Pharmaceuticals in Q2 2023 and continued to invest until Q1 2025. Since then they sold 707k shares. The stake costed the investor $313M, netting the investor a gain of 112% so far.

Avg closing price
Price range
Sold 18.5% shares (-315k shares) Q1 2026
Avg closing price $482.74
Price range $425.85 - $593.87
Sold 10.5% shares (-200k shares) Q4 2025
Avg closing price $512.13
Price range $412.35 - $602.83
Sold 8.7% shares (-182k shares) Q3 2025
Avg closing price $372.94
Price range $287.52 - $458.66
Sold 0.5% shares (-10k shares) Q2 2025
Avg closing price $297.20
Price range $267.56 - $334.60
Increased shares by 2.8% (+57.5k shares) Q1 2025
Avg closing price $328.25
Price range $272.79 - $355.88
Increased shares by 10.4% (+192k shares) Q3 2024
Avg closing price $255.94
Price range $212.22 - $292.96
Increased shares by 4.2% (+75k shares) Q2 2024
Avg closing price $238.04
Price range $193.33 - $291.99
Increased shares by 60.5% (+669k shares) Q1 2024
Avg closing price $235.62
Price range $171.37 - $283.23
Increased shares by 121.1% (+606k shares) Q4 2023
Avg closing price $174.99
Price range $120.40 - $237.13
Increased shares by 42.8% (+150k shares) Q3 2023
Avg closing price $188.22
Price range $146.04 - $225.78
New holding (+350k shares) Q2 2023
Avg closing price $270.85
Price range $203.88 - $312.00

News about Madrigal Pharmaceuticals Inc and John Paulson

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!